Stockreport

Assessing Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of NEREUS For Motion Sickness [Yahoo! Finance]

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report
PDF This approval ends a four decade gap in motion sickness treatments. See our latest analysis for Vanda Pharmaceuticals. That FDA approval comes after a sharp run, wit [Read more]